Throughout 2024/2025, QBI researchers have continued to make new discoveries, advancing research into new treatments for neurological conditions. We have highlighted some of this work in our latest Research Impact Report.
Professor John McGrath has led a significant study that has found evidence that people with lower vitamin D concentration as babies have an increased risk of later developing mental disorders such as ADHD, schizophrenia and autism spectrum disorder.
A new review explores how exercise can reduce the risk of dementia and promote healthy brain ageing, suggesting we need to re-think global exercise guidelines.
Determined to honour her brother's life and help others battling Parkinson's, Lynda established the Ray Clarke Endowment Fund at QBI to support vital research.
As an electrophysiologist Dr. Margreet Ridder is pioneering a new wave of discovery science to understand the causes and progression of motor neurone disease (MND).
Queensland Brain Institute researchers have discovered a potential link between inflammation, metabolic dysfunction, and treatment-resistant depression
Aileen Hamilton generously bequeathed her Bulimba property to the Queensland Brain Institute, to further brain injury research, in honour of her son, Ronnie, who lived with an acquired brain injury.
Researchers have found that giving mice real-time sounds linked to their movements during a task helps them learn motor skills faster, paving the way for further studies to improve our understanding of motor skills learning.
Alison Carlisle claimed first prize in the annual scientific art competition for her work titled ‘Projections and trajectories’, which offers a detailed portrayal of neural stem cells in the hippocampus.
As a part of UQ’s Research and Innovation Week, the Queensland Brain Institute (QBI) invited the community to QBI for an interactive presentation and panel discussion exploring memory.
QBI researchers have discovered that nearly 70 per cent of suspected frontotemporal dementia patients ultimately did not have the disease in a study aimed at identifying factors that contribute to misdiagnosis of the disorder.
QBI researchers have discovered a molecule that protects brain cells from oxidative stress and damage, opening new avenues for possible treatments for brain diseases.
NuNerve, a company formed to commercialise research from UQ’s Queensland Brain Institute, has produced successful results in a human clinical trial for potential new treatment for MND.
In November 2024, the Queensland Brain Injury Collaborative (QBIC) held its annual symposium at the Atrium in Brisbane City, bringing together almost 100 researchers, health professionals, policymakers, and individuals living with brain injury.
In early November 2024, health professionals and community members from Toowoomba were invited to a brain injury showcase designed at improving care across the trajectory of acquired brain injury.
Researchers have discovered an alternative pathway for how viruses, including SARS-CoV-2 enter host cells, offering new potential treatment modalities.
